| Literature DB >> 20837192 |
Abstract
Although the pain of fibromyalgia usually is not preceded by an injury to the involved tissue, whereas that of the complex regional pain syndrome usually starts at a site of prior trauma or surgery, both disorders may share a common mechanism-pathologic sensitization of brain mechanisms that integrate nociceptive signals-and both apparently respond to treatment with ketamine, an anesthetic-analgesic agent whose actions include blockade of N-methyl-D-aspartate receptors. Ketamine's widespread illegal use as a recreational agent probably precludes developing it as a general treatment of centrally mediated pain disorders; however, its efficacy suggests that related, to-be-discovered agents could be useful.Entities:
Mesh:
Substances:
Year: 2010 PMID: 20837192 DOI: 10.1016/j.metabol.2010.07.008
Source DB: PubMed Journal: Metabolism ISSN: 0026-0495 Impact factor: 8.694